In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Paul Guedeney
Speaker
Paul Guedeney
Paul Guedeney Paul Guedeney

Hospital Pitie-Salpetriere, Paris (France)

Specialities : Acute Coronary Syndromes , Interventional Cardiology, Valvular Heart Disease

2017. M.D. in Cardiology and vascular disease (Paris Sorbonne University). 2017-2018. Research scholar at the Zena and Michael A. Weiner Cardiovascular Institute, Icahn school of medicine at Mount Sinai, under the direction of Dr Roxana Mehran. 2018-Today. Interventional cardiology Fellow at the cardiology Institute, Pitié Salpêtrière Hospital, Paris, France, under the direction of Pr Montalescot.

10 presentations from this speaker

Long term follow-up after percutaneous closure of patent foramen ovale for secondary prevention of stroke

Event : ESC Congress 2019

  • Session : Non-coronary cardiac intervention
  • Speaker : P Guedeney (Paris,FR)

Prognostic impact of SYNTAX Score in patients with myocardial infarction with multivessel coronary artery disease and cardiogenic shock: insight from the CULPRIT-SHOCK Trial

Event : ESC Congress 2019

  • Session : Advances in revascularisation strategies in patients with multivessel disease
  • Speaker : P Guedeney (Paris,FR)

Impact of oral anticoagulation on clinical outcomes and hemodynamic parameters after successful transcatheter aortic valve replacement

Event : ESC Congress 2018

  • Session : Best Posters in non coronary cardiac interventions
  • Speaker : P Guedeney (Paris,FR)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are